Results 1 to 10 of about 32,411 (197)
A History of Thrombolytic Therapy
Thrombolytic therapy has been available for the last 5 decades, but the modern era of thrombolysis began in the early 1990s, with the execution of 3 multicenter trials designed to compare this potentially less invasive therapy to the then standard of care for acute limb ischemia, open surgical revascularization.
exaly +3 more sources
Knowledge of thrombolytic therapy for acute ischemic stroke among community residents in western urban China. [PDF]
Thrombolytic therapy rate for acute ischemic stroke remains low, and improving public awareness of thrombolytic therapy may be helpful to reduce delay and increase chances of thrombolytic therapy.
Juan Yang +7 more
doaj +1 more source
Objective: Neutrophil to lymphocyte (NLR) and platelet to lymphocyte (PLR) ratios play an important role in monitoring the progression of the disease and determining the course of the disease in patients with acute pulmonary thromboembolism (APTE).
Ayhan Coşgun, Hüseyin Ören
doaj +1 more source
Assessment and prognostic value of serum uric acid (SUA) and neuron-specific enolase (NSE) on the efficacy of intravenous thrombolytic therapy in cerebral infarction.
Yanjing Zang +4 more
doaj +1 more source
Repeated Thrombolytic Therapy in Patients with Recurrent Acute Ischemic Stroke [PDF]
Background and PurposeWidespread use of thrombolytic treatments, along with improved chances of survival after an initial ischemic stroke, increases the possibility of repeated thrombolysis. There are few reports, however, regarding repeated thrombolysis
Han Soo Yoo +9 more
doaj +1 more source
Presented clinical case report illustrates nonstandart approach use repeat thrombolytic therapy patient 49 y.o. with acute circular – apical myocardial infarction, after noneffective primary systemic thrombolytic therapy rtPA.
D. V. Bosikov +3 more
doaj +1 more source
Tratamento trombolítico do enfarte agudo do miocárdio. Primeira de três partes.
I-Rationale of thrombolytic therapy in acute myocardial infarction (AMI). II-Thrombolytic drugs. III-Effects of thrombolytic therapy on mortality. IV-Studies comparing the effects of various thrombolytic agents on mortality.
J T Soares-Costa +2 more
doaj +1 more source
Background: Thrombolytic therapy in patients with sub-massive pulmonaryembolism (SMPTE) needs further assessment. Objectives: The current study aimed to assess a potential benefit of thrombolytic and non-thrombolytic therapy in patients with SMPTE ...
Hasan Allah Sadeghi +4 more
doaj +1 more source
Objectives: Ventricular septal rupture (VSR) is a rare but feared complication after myocardial infarction (MI). The objective of this study was to investigate the effects of thrombolytic therapy on the patterns of VSR following MI.
Sunil Kumar Srinivas +3 more
doaj +1 more source

